Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志
中国生物工程杂志  2010, Vol. 30 Issue (06): 1-7    
研究报告     
STAT3基因沉默降低小鼠乳腺癌细胞的体外迁移能力
徐良,顾玉超,时瀚,宓文义,于文功**
中国海洋大学医药学院 青岛 266003
STAT3 Silencing Inhibits Migration of Murine Breast Cancer Cells in vitro
XU Liang,GU Yu-chao,SHI Han,MI Wen-yi,YU Wen-gong
College of Medicine and Pharmaceutics Ocean University of China, Qingdao 266003,China
 全文: PDF(700 KB)   HTML
摘要：

信号转导子与转录活化子3(STAT3)是一个具有信号转导和转录调控双重功能的转录因子，有文献报道STAT3在乳腺癌中的表达显著升高，并能促进乳腺癌的转移。为了深入探索STAT3在肿瘤发生发展中的作用和影响乳腺癌转移的分子机制，采用RNA干扰技术在小鼠乳腺癌细胞株4T1中沉默STAT3的表达。MTT实验结果显示STAT3沉默对4T1细胞的增殖能力没有影响；细胞迁移实验结果表明STAT3表达被沉默后4T1细胞的迁移能力明显被抑制；定量PCR结果显示，STAT3基因沉默后4T1细胞中VEGF和IL-6的mRNA水平下降，E-cadherin表达上升，mosin表达下降；信号通路检测显示STAT3基因表达沉默后MAPK的活化明显降低。研究表明STAT3在小鼠乳腺癌细胞的迁移过程中发挥重要作用，为以STAT3基因为靶向的治疗提供了一定的实验依据。
关键词： STAT3;  乳腺癌;  RNA干扰;  细胞迁移    
Abstract:

STAT3 (signal transducer and activator of transcription 3) is a dual functional transcription factor with functions as signal transduction and transcription regulation. There are reports that the expression of STAT3 in breast cancer is significantly higher and STAT3 can facilitate breast cancer metastasis. To clarify the definite effect and molecular mechanism of STAT3’s involvement in breast cancer metastasis, STAT3 was silenced by RNAi in the murine highly metastatic 4T1 cells. The silencing of STAT3 didn’t affect the proliferation rate of breast cancer 4T1 cells in MTT assay. However, the migration activity of STAT3 knockdown cells was strongly reduced in Transwell assay. The real-time quantitative PCR results indicated that STAT3 silencing significantly suppressed the expression of VEGF, IL-6 and mosin, while increased E-cadherin expression. Western Blot assay showed that phosphorylation level of MAPK was reduced in STAT3 knockdown cells. The results of this study demonstrate that STAT3 plays an important role in breast cancer metastasis and provide experimental evidences in therapy with STAT3 as a target.
Key words: STAT3    Breast cancer    RNAi    Tumor migration
收稿日期: 2010-01-07 出版日期: 2010-06-12
基金资助:

国家“973”计划资助项目（2003CB716402）
通讯作者: 于文功     E-mail: yuwg66@ouc.edu.cn
服务　　
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章　　
徐良
顾玉超
时瀚
宓文义
于文功

引用本文:

徐良 顾玉超 时瀚 宓文义 于文功. STAT3基因沉默降低小鼠乳腺癌细胞的体外迁移能力[J]. 中国生物工程杂志, 2010, 30(06): 1-7.

XU Liang, GU Yu-Chao, SHI Han, FU Wen-Xi, XU Wen-Gong. STAT3 Silencing Inhibits Migration of Murine Breast Cancer Cells in vitro. China Biotechnology, 2010, 30(06): 1-7.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/    或    https://manu60.magtech.com.cn/biotech/CN/Y2010/V30/I06/1

［1］ O’Sullivan L A, Liongue C, Lewis R S, et al. Cytokine receptor signaling through the JakStatSocs pathway in disease. Mol Immunol, 2007, 44(10): 24972506. 
［2］ Huang F, Tong X, Fu L, et al. Knockdown of STAT3 by shRNA inhibits the growth of CAOV3 ovarian cancer cell line in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai), 2008, 40(6): 519525. 
［3］ Burke W M, Jin X, Lin H J, et al. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene, 2001, 20(55): 79257934. 
［4］ Azare J, Leslie K, AlAhmadie H, et al. Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6. Mol Cell Biol, 2007, 27(12): 44444453. 
［5］ Gao S P, Bromberg J F. Touched and moved by STAT3. Sci STKE, 2006, 343: 30. 
［6］ Kira M, Sano S, Takagi S, et al. STAT3 deficiency in keratinocytes leads to compromised cell migration through hyperphosphorylation of p130(cas). J Biol Chem, 2002, 277(15): 1293112936. 
［7］ Itoh M, Murata T, Suzuki T, et al. Requirement of STAT3 activation for maximal collagenase1 (MMP1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. Oncogene, 2006, 25(8): 11951204. 
［8］ Silver D L, Naora H, Liu J, et al. Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res, 2004, 64(10): 35503558. 
［9］ Zhang F, Li C, Halfter H, et al. Delineating an oncostatin Mactivated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF7 cells. Oncogene, 2003, 22(6): 894905. 
［10］ Ling X, Arlinghaus R B. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. Cancer Res, 2005, 65(7): 25322536. 
［11］ Ng D C, Lin B H, Lim C P, et al. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol, 2006, 172(2): 245257. 
［12］ Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumor microenvironment. Nat Rev Immunol, 2007, 7(1): 4151. 
［13］ Huang S. Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res, 2007, 13(5): 13621366. 
［14］ Wang T, Niu G, Kortylewski M, et al. Regulation of the innate and adaptive immune responses by Stat3 signaling in tumor cells. Nat Med, 2004, 10(1): 4854. 
［15］ Kortylewski M, Kujawski M, Wang T, et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med, 2005, 11(12): 13141321. 
［16］ Badache A, Hynes N E. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Cancer Res, 2001, 61(1): 383391. |
［17］ Wegiel B, Bjartell A, Culig Z, et al. Interleukin6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int J Cancer, 2008, 122(7): 15211529.
[1] 冯昭,李江浩,王佳华. 刺槐核糖体蛋白同源基因RpRPL22在共生结瘤过程中功能研究[J]. 中国生物工程杂志, 2021, 41(7): 10-21.
[2] 路玉祥,李元,方丹丹,王学博,杨万鹏,楚元奎,杨华. MiR-5047在乳腺癌细胞增殖迁移中的作用及表达调控*[J]. 中国生物工程杂志, 2021, 41(4): 9-17.
[3] 林璐,户丽君,黄逸云,陈露,黄茂,彭棋,胡琴,周兰. S100A6通过招募和活化巨噬细胞促进血管形成*[J]. 中国生物工程杂志, 2020, 40(5): 7-14.
[4] 何秀娟,胡凤枝,刘秋丽,刘玉萍,祝玲,郑文云. 乳腺癌细胞QSOX1的CRISPR/Cas9基因编辑及其对增殖侵袭的影响研究*[J]. 中国生物工程杂志, 2020, 40(11): 1-9.
[5] 先洁,覃雪,曹友德. Numb在三阴乳腺癌中抑制HDM2泛素化降解p53 *[J]. 中国生物工程杂志, 2019, 39(7): 1-7.
[6] 程瑜,施琼,安利钦,范梦恬,皇改改,翁亚光. BMP7基因沉默抑制钙盐诱导猪主动脉瓣膜间质细胞成骨分化 *[J]. 中国生物工程杂志, 2019, 39(5): 63-71.
[7] 陈露,黄茂,彭棋,赵佳丽,谢佳卿,林璐,户丽君,黄逸云,胡琴,周兰. S100A6通过巨噬细胞促结直肠癌细胞增殖的作用及机制 *[J]. 中国生物工程杂志, 2019, 39(4): 1-7.
[8] 万群,刘梦瑶,夏菁,苟理尧,唐敏,孙恃雷,张彦. 长链非编码RNA SNHG3对人乳腺癌细胞MCF-7增殖、迁移与侵袭的影响 *[J]. 中国生物工程杂志, 2019, 39(1): 13-20.
[9] 苟理尧,刘梦瑶,夏菁,万群,孙恃雷,唐敏,张彦. 骨形成蛋白9对人膀胱癌BIU-87细胞增殖和迁移的影响[J]. 中国生物工程杂志, 2018, 38(5): 10-16.
[10] 冯昭,丑敏霞. Rpfan37在刺槐共生结瘤过程中的功能探究 *[J]. 中国生物工程杂志, 2018, 38(5): 47-55.
[11] 李依蔓,周钦. Herpud1对后肾间充质细胞的作用及其机制的探讨*[J]. 中国生物工程杂志, 2018, 38(3): 9-15.
[12] 董维鹏,张少华,许祥,燕炯. 下调Fsp27基因表达联合杨梅素干预对3T3-L1细胞脂解的影响[J]. 中国生物工程杂志, 2018, 38(12): 7-13.
[13] 冯源, 唐云, 徐蕾, 谭海刚. 海藻多糖通过下调肝癌细胞Hep3B糖酵解途径抑制细胞增殖和迁移[J]. 中国生物工程杂志, 2017, 37(9): 31-40.
[14] 代立婷, 吴忠南, 黄翔, 杨杰, 曾慧兰, 王国才, 蒋建伟. 卤地菊乙醇提取物W40单体诱导GLC-82细胞凋亡的分子机制研究[J]. 中国生物工程杂志, 2017, 37(8): 1-7.
[15] 孙元元, 李薇, 叶守东, 刘大海. Gadd45g诱导小鼠胚胎干细胞向中内胚层分化[J]. 中国生物工程杂志, 2017, 37(4): 9-17.
主管：中国科学院 　主办：中国科学院文献情报中心 　中国生物技术发展中心 　中国生物工程学会